Leslie Williams

773 total citations
17 papers, 424 citations indexed

About

Leslie Williams is a scholar working on Physiology, Epidemiology and Gastroenterology. According to data from OpenAlex, Leslie Williams has authored 17 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 6 papers in Epidemiology and 5 papers in Gastroenterology. Recurrent topics in Leslie Williams's work include Alzheimer's disease research and treatments (6 papers), Microscopic Colitis (5 papers) and Celiac Disease Research and Management (5 papers). Leslie Williams is often cited by papers focused on Alzheimer's disease research and treatments (6 papers), Microscopic Colitis (5 papers) and Celiac Disease Research and Management (5 papers). Leslie Williams collaborates with scholars based in United States, Australia and Switzerland. Leslie Williams's co-authors include Jeff Sevigny, John O’Gorman, Alvydas Mikulskis, J L Ferrero, Rachel Jakobowicz, Robert P. Anderson, A. James M. Daveson, Kaela E. Goldstein, Jason A. Tye–Din and Gautam Goel and has published in prestigious journals such as Neurology, Pain and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Leslie Williams

16 papers receiving 408 citations

Peers

Countries citing papers authored by Leslie Williams

Since Specialization

Citations

This map shows the geographic impact of Leslie Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie Williams more than expected).

Fields of papers citing papers by Leslie Williams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leslie Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie Williams. The network helps show where Leslie Williams may publish in the future.

Co-authorship network of co-authors of Leslie Williams

This figure shows the co-authorship network connecting the top 25 collaborators of Leslie Williams. A scholar is included among the top collaborators of Leslie Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leslie Williams. Leslie Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Dichloroacetate as a possible treatment for endometriosis-associated pain: a single-arm open-label exploratory clinical trial (EPiC) 2021 ·Pilot and Feasibility Studies ·(unknown), (unknown), Leslie Williams, Philippa T. K. Saunders, Jane Daniels, (unknown), (unknown), (unknown), Yu Z. Bagger, Andrew W. Horne, Lucy Whitaker	12
2	Patient factors influencing acute gluten reactions and cytokine release in treated coeliac disease 2020 ·BMC Medicine ·(unknown), Jason A. Tye–Din, A. James M. Daveson, Kaela E. Goldstein, (unknown), Kristin D. Neff, Gautam Goel, Leslie Williams, Kenneth E. Truitt, Robert P. Anderson	30
3	A19 NOVEL HLA-DQ2 TRANSGENIC MICE DEVELOP GLUTEN-IMMUNOPATHOLOGY FOLLOWING GLUTEN SENSITIZATION 2020 ·Journal of the Canadian Association of Gastroenterology ·(unknown), Heather J. Galipeau, Jennifer Jury, (unknown), (unknown), Leslie Williams, (unknown), Elena F. Verdú	1
4	Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease 2019 ·Alimentary Pharmacology & Therapeutics ·A. James M. Daveson, Jason A. Tye–Din, Gautam Goel, Kaela E. Goldstein, (unknown), Kristin D. Neff, Leslie Williams, Kenneth E. Truitt, Robert P. Anderson, (unknown)	28
5	Serum cytokines elevated during gluten-mediated cytokine release in coeliac disease 2019 ·Clinical & Experimental Immunology ·Gautam Goel, A. James M. Daveson, (unknown), Jason A. Tye–Din, (unknown), (unknown), Leslie Williams, John L. Dzuris, Kristin D. Neff, Kenneth E. Truitt, Robert P. Anderson	39
6	Epitope-Specific Immunotherapy Targeting CD4-Positive T Cells in Celiac Disease: Safety, Pharmacokinetics, and Effects on Intestinal Histology and Plasma Cytokines with Escalating Dose Regimens of Nexvax2 in a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study 2017 ·EBioMedicine ·A. James M. Daveson, Hooi C. Ee, Jane M. Andrews, Timothy J. King, Kaela E. Goldstein, John L. Dzuris, James A. MacDougall, Leslie Williams, (unknown), Michael Cooreman, Robert P. Anderson	47
7	Titration dosing of aducanumab: Results of a 12-month interim analysis from a randomized, double-blind, placebo-controlled Phase 1b study (PRIME) in patients with prodromal or mild Alzheimer’s Disease (S7.003) 2017 ·Neurology ·Vissia Viglietta, John O’Gorman, Leslie Williams, Tianle Chen, Ahmed Enayetallah, Ping Chiao, Christoph Höck, Roger M. Nitsch, Samantha Budd Haeberlein, Alfred Sandrock	2
8	[P1–053]: CHANGE FROM BASELINE IN CLINICAL DEMENTIA RATING SCALE COGNITIVE AND FUNCTIONAL DOMAINS IN PRIME, A RANDOMIZED PHASE 1B STUDY OF THE ANTI–AMYLOID BETA MONOCLONAL ANTIBODY ADUCANUMAB (BIIB037) 2017 ·Alzheimer s & Dementia ·Vissia Viglietta, John O’Gorman, Leslie Williams, Tianle Chen, Ahmed Enayetallah, Christoph Höck, Roger M. Nitsch, Samantha Budd Haeberlein, Alfred Sandrock	1
9	Safety and efficacy of neublastin in painful lumbosacral radiculopathy: a randomized, double-blinded, placebo-controlled phase 2 trial using Bayesian adaptive design (the SPRINT trial) 2017 ·Pain ·Miroslav Bačkonja, Leslie Williams, Xiaopeng Miao, Nathaniel P. Katz, (unknown)	23
10	Randomized, Double-Blind, Placebo-Controlled Studies to Evaluate Treatment with Aducanumab (BIIB037) in Patients with Early Alzheimer’s Disease: Phase 3 Study Design (S1.003) 2016 ·Neurology ·Vissia Viglietta, John O’Gorman, Leslie Williams, Ying Tian, Alfred Sandrock, Rachelle S. Doody, Stephen Salloway, Frederik Barkhof, Bruno Vellas, Mary Sano, Paul Aisen, Jeffrey Sevigny	9
11	P1‐040: Clinical Dementia Rating‐Sum of Boxes Responder Analysis in Prime: A Randomized Phase 1B Study of the Anti‐Amyloid Beta Monoclonal Antibody Aducanumab (BIIB037) 2016 ·Alzheimer s & Dementia ·Vissia Viglietta, John O’Gorman, Leslie Williams, Tianle Chen, Ping Chiao, Brendon Boot, Christoph Höck, Roger M. Nitsch, Alfred Sandrock	0
12	First‐in‐human, double‐blind, placebo‐controlled, single‐dose escalation study of aducanumab (BIIB037) in mild‐to‐moderate Alzheimer's disease 2016 ·Alzheimer s & Dementia Translational Research & Clinical Interventions ·J L Ferrero, Leslie Williams, (unknown), (unknown), Alvydas Mikulskis, John O’Gorman, Jeff Sevigny	132
13	Pharmacokinetics and pharmacodynamics of multiple doses of BG00010, a neurotrophic factor with anti‐hyperalgesic effects, in patients with sciatica 2016 ·British Journal of Clinical Pharmacology ·(unknown), Justin L. Hay, Eve Versage, Yongqiang Tang, Gerald R. Galluppi, Bernard Ravina, Ajay Verma, Leslie Williams, Ernesto Aycardi, Geert Jan Groeneveld	16
14	Randomized, placebo-controlled, phase 1b study of anti-beta-amyloid antibody aducanumab (biib037) in prodromal ad/mild ad dementia: Interim results by patient subgroup 2015 ·Journal of the Neurological Sciences ·Jeffrey Sevigny, Ping-Chun Chiao, Leslie Williams, Tianle Chen, Ling Yan, John O’Gorman, C. Hock, Roger M. Nitsch, Alfred Sandrock	1
15	O4‐04‐05: Aducanumab (BIIB037), an anti‐amyloid beta monoclonal antibody, in patients with prodromal or mild Alzheimer's disease: Interim results of a randomized, double‐blind, placebo‐controlled, phase 1b study 2015 ·Alzheimer s & Dementia ·Jeff Sevigny, Ping Chiao, Leslie Williams, Tianle Chen, Ling Yan, John O’Gorman, Christoph Höck, Roger M. Nitsch, Alfred Sandrock	32
16	Covert modeling vs. behavior rehearsal in the training and generalization of assertive behaviors: A crossover design 1979 ·Journal of Clinical Psychology ·(unknown), Leslie Williams	4
17	Immunization of Rh‐Negative Volunteers by Repeated Injections of Very Small Amounts of Rh‐Positive Blood 1972 ·Vox Sanguinis ·Rachel Jakobowicz, Leslie Williams, (unknown)	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact